Vasopressin Antagonism in Heart Failure
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (10) , 1785-1791
- https://doi.org/10.1016/j.jacc.2005.02.095
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Furosemide and the progression of left ventricular dysfunction in experimental heart failureJournal of the American College of Cardiology, 2004
- Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effectsAmerican Heart Journal, 2003
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Vasopressin: A therapeutic target in congestive heart failure?Journal of Cardiac Failure, 1999
- Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captoprilJournal of the American College of Cardiology, 1994
- Vasopressin and arterial pressure regulation. Special lecture.Hypertension, 1988
- Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit.Journal of Clinical Investigation, 1986
- Increased plasma arginine vasopressin levels in patients with congestive heart failureJournal of the American College of Cardiology, 1983
- Plasma and platelet vasopressin in essential hypertension and congestive heart failure.Hypertension, 1983
- Radioimmunoassay of Plasma Arginine Vasopressin in Hyponatremic Patients with Congestive Heart FailureNew England Journal of Medicine, 1981